Incidence and prevalence of idiopathic pulmonary fibrosis.

RATIONALE Idiopathic pulmonary fibrosis is a chronic interstitial lung disease of unknown etiology; its epidemiology in the United States has not been well characterized. OBJECTIVE To estimate the annual incidence and prevalence of idiopathic pulmonary fibrosis in the United States. METHODS Retrospective cohort design utilizing a large health care claims database spanning the period January 1996 through December 2000. MEASUREMENTS AND MAIN RESULTS Persons with idiopathic pulmonary fibrosis were identified based on diagnosis and procedure codes. Using broad case-finding criteria, prevalence was estimated to range from 4.0 per 100,000 persons aged 18 to 34 yr to 227.2 per 100,000 among those 75 yr or older; annual incidence was estimated to range from 1.2 to 76.4 per 100,000. Using narrow case-finding criteria, prevalence ranged from 0.8 to 64.7 per 100,000 persons; comparable figures for incidence were 0.4 to 27.1 per 100,000 persons. Extrapolating these rates to the overall United States' population, prevalence was estimated to be 42.7 per 100,000 (incidence, 16.3 per 100,000) using broad criteria; with narrow criteria, prevalence was estimated to be 14.0 per 100,000 (incidence, 6.8 per 100,000). CONCLUSIONS Our results suggest that idiopathic pulmonary fibrosis is probably more common in the United States than previously reported.

[1]  G. Oster,et al.  Prevalence and Economic Burden of Bronchiectasis , 2005 .

[2]  F. Martinez,et al.  The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis , 2005, Annals of Internal Medicine.

[3]  A. Shorr,et al.  Outcomes and safety of surgical lung biopsy for interstitial lung disease. , 2005, Chest.

[4]  F. Martinez,et al.  Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? , 2004, American journal of respiratory and critical care medicine.

[5]  G. Raghu,et al.  A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. , 2004, The New England journal of medicine.

[6]  Frank A Sloan,et al.  Longitudinal prevalence of major eye diseases. , 2003, Archives of ophthalmology.

[7]  A. Gulsvik,et al.  Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. , 2003, Respiratory medicine.

[8]  E. Finkelstein,et al.  Prevalence and costs of major depression among elderly claimants with diabetes. , 2003, Diabetes care.

[9]  J. Goodwin,et al.  Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. , 2002, Health services research.

[10]  T. Laitinen,et al.  Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland , 2002, Thorax.

[11]  R. Strawderman,et al.  Clinical significance of histological classification of idiopathic interstitial pneumonia , 2002, European Respiratory Journal.

[12]  I. D. Johnston,et al.  American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002 .

[13]  T. Gilmer,et al.  Prevalence, expenditures, utilization, and payment for persons with MS in insured populations , 2002, Neurology.

[14]  T. Mclaughlin,et al.  Prevalence of treated dry eye disease in a managed care population. , 2001, Clinical therapeutics.

[15]  J. Tooze,et al.  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. , 2001, American journal of respiratory and critical care medicine.

[16]  D. Knopman,et al.  Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. , 2001, The American journal of managed care.

[17]  D. Lynch,et al.  Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. , 2001, American journal of respiratory and critical care medicine.

[18]  M. Demedts,et al.  REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS , 2001, Acta clinica Belgica.

[19]  A. Pardo,et al.  Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy , 2001, Annals of Internal Medicine.

[20]  H. Wong,et al.  Selection Bias in HMOs: A Review of the Evidence , 2000, Medical care research and review : MCRR.

[21]  S. Aguayo,et al.  Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management. , 2000, Chest.

[22]  J. Egan.  New treatments for pulmonary fibrosis? , 1999, The Lancet.

[23]  G. Raghu,et al.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. , 1999, Chest.

[24]  M A Schork,et al.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival. , 1998, American journal of respiratory and critical care medicine.

[25]  R. G. Parrish,et al.  Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. , 1996, American journal of respiratory and critical care medicine.

[26]  W. Black,et al.  The epidemiology of interstitial lung diseases. , 1994, American journal of respiratory and critical care medicine.

[27]  V. Kolek.  Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia. , 1994, Acta Universitatis Palackianae Olomucensis Facultatis Medicae.

[28]  D. Schwartz,et al.  Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[29]  W. Thurlbeck,et al.  Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. , 1991, The American review of respiratory disease.

[30]  I. D. Johnston,et al.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. , 1990, BMJ.

[31]  T. King,et al.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.

[32]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[33]  M. Lebowitz,et al.  Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease. , 1975, American journal of epidemiology.

[34]  M. Lebowitz,et al.  Tucson epidemiologic study of obstructive lung diseases. II: Effects of in-migration factors on the prevalence of obstructive lung diseases. , 1975, American journal of epidemiology.

[35]  W. Travis,et al.  Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. , 2000, The American journal of surgical pathology.

[36]  David A. Lynch,et al.  Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement , 2000 .

[37]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[38]  R. Klocke,et al.  THE AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE , 1994 .